Notification from Sopharma AD under Art. 44n of ORDINANCE № 13 of 22.12.2003
In conjunction with the tender offering made on the grounds of Art. 149 para. 6 of the Public Offering of Securities Act and the right of the shareholders who have not accepted the offer under Art. 157b, we provide information for the fulfillment of the obligation of Sopharma AD under this Article:
1. The offeror has bought a total of 125 530 shares with voting right of Unipharm AD;
2. 17 shareholders have applied for share buy-back under the right given to them by Art. 157b of POSA.
Insider trading disclosure of September, 26 2017 received by Rositsa Doneva
Insider trading disclosure of September, 26 2017 received by Sopharma AD
Notification for acquisition of own shares
SOPHARMA AD hereby informs that on 21 September 2017 the Company bought 6635 own shares representing 0.0049% of the share capital of the Company, at a total value of 28750.33.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.33 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.
Insider trading disclosure of September, 21 2017 received by Ognian Donev
Insider trading disclosure of September, 21 2017 received by Sopharma AD
Insider trading disclosure of September, 20 2017 received by DIH
Notification for acquisition of own shares
SOPHARMA AD hereby informs that from 20 September 2017 the Company bought 5650 own shares representing 0.0042% of the share capital of the Company, at a total value of 24 441.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.33 BGN.
The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.